- Over 7,500 people expected to attend Cannabis Business Summit & Expo
- More than 85 percent of attendees to have decision-making or purchasing authority
- EVIO Colorado licensee gets ISO approval for pesticide testing
- Cannabis testing market to hit $1.4 billion by 2021
EVIO Inc. (OTCQB: EVIO), an accredited and established leader in cannabis testing, is set to exhibit at one of the nation’s foremost cannabis trade shows. EVIO will have booth #1113 at the National Cannabis Industry Association’s (NCIA) 5th Annual Cannabis Business Summit & Expo coming to San Jose, California, on July 25-27 (http://nnw.fm/ms8PN).
Over 7,500 attendees are expected at the event, which will bring together policymakers and key actors in the cannabis industry. Conference organizers estimate that over 85 percent of the attendees will have either decision-making or purchasing authority, making it a prime networking and deal-making opportunity.
“California’s heightened cannabis testing standards which went into effect on July 1, have brought cannabis testing and consumer safety to the forefront of the conversation. We are looking forward to connecting with NCIA attendees to discuss the new regulations and answer any questions regarding the testing space,” Al Lustig, president of EVIO Labs, stated in a news release. Lustig added that both EVIO and the cannabis testing space are growing at a rapid pace, “and the momentum will continue as more states and countries’ recreational programs come online.”
Confirming this increased growth and capacity, EVIO has also announced that one of its licensees has been certified to test cannabis products for pesticides (http://nnw.fm/VUBg5). PhytaTech CO has been awarded ISO 17025 Certification for Pesticide Analysis in the State of Colorado. This the highest international standard for a laboratory’s competence and quality. The certification assures customers, public officials and accreditation bodies that tests are performed with impartiality and consistency.
“While pesticide testing is not state-mandated, we predict that it will be in the following months as the focus continues towards consumer safety and ensuring that products are clean and of the highest quality,” said Stephen Goldman, laboratory director of PhytaTech. “Pesticide residues are an extremely important public safety issue and something that has been plaguing the industry for years. EVIO remains committed to upholding the highest standards of the testing process and instilling consumer confidence in this expanding industry.”
Denver-based PhytaTech has been operating since 2014 and entered a licensing agreement with EVIO in 2017. The agreement allows PhytaTech to use EVIO’s testing methods. PhytaTech works with licensed producers in Colorado’s cannabis industry. It carries out potency analysis and tests products for contaminants, aiming to work at a 48-hour turnaround time.
The cannabis testing market is expected to reach $1.4 billion by 2021 (http://nnw.fm/aQX8h). More and more states are legalizing marijuana for medical and recreational use, and these new laws are often coupled with mandated testing. With nine testing labs in California, Florida, Oregon, Massachusetts and Colorado, and plans to double this number by the end of the year, EVIO is set to capitalize on mandatory testing to further support its growth. The company offers a wide range of screening and analysis services to the regulated cannabis industry, as well as research and development for new cannabis products, and consultancy to cannabis growers and producers to meet quality goals, optimize manufacturing processes and achieve regulatory compliance.
For more information, visit the company’s website at www.EVIOLabs.com
More from NetworkNewsWire
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
